Angiotensin II Type 1 Receptor Blockers and Congestive Heart Failure
نویسندگان
چکیده
منابع مشابه
Angiotensin II type 1 receptor blockers and congestive heart failure.
Congestive Heart Failure To the Editor: We read with great interest the review on angiotensin II type 1 receptor blockers by Michel Burnier.1 He quotes previous investigations, including the results of the Losartan Heart Failure Survival Study (ELITE II)2 and states that “. . .losartan was not superior to captopril in reducing morbidity and mortality. . .,” and concludes that “. . .one should b...
متن کاملAngiotensin II type 1 receptor blockers.
In the 1970s, a series of observations demonstrated that angiotensin II has deleterious effects on the heart and kidney and that patients with high levels of plasma renin activity are at a higher risk of developing stroke or myocardial infarction than those with low plasma renin activity.1,2 Thereafter, the development of pharmacological probes that block the renin-angiotensin system helped def...
متن کاملAre angiotensin II receptor blockers indicated in chronic heart failure?
Chronic heart failure is one of the most serious cardiac problems encountered in clinical practice. Modulation of the renin angiotensin system is a key element in the treatment of this syndrome. There is overwhelming evidence in favour of the benefit of angiotensin converting enzyme (ACE) inhibitors on morbidity and mortality in mild to severe heart failure and in heart failure or left ventricu...
متن کاملMichel Burnier Angiotensin II Type 1 Receptor Blockers
Angiotensin II Type 1 Receptor Blockers Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2001 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.103.6.904 2001;103:904-912 Circulation. http://circ.ahajournals.org/content/103/6/904 World Wide Web at: The online ver...
متن کاملFunctional role of endogenous endothelin-1 in congestive heart failure treated with angiotensin II receptor antagonist.
Interactions between angiotensin (ANG) II and endothelin (ET)-1 receptor transduction pathways have been unclear in congestive heart failure (CHF). Therefore the objects of this study are, in CHF, whether production of ET-1 is modulated by ANG II and/or whether hemodynamic effects of endogenous ET-1 are modulated by ANG II. Twelve dogs were randomly assigned to two groups: untreated (n = 6) and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2001
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circ.104.15.e82